 |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
The Fifth Annual Clinical Investigator’s course, co-sponsored by the Food and Drug Administration’s office of Medical Policy and the Duke School of Medicine is now open for registration. The dates for the course are Nov 12-14, 2013. The venue is The Holiday Inn, College Park, MD 20740. The booking group code for your Clinical Investigation Training in November is “CTT”; individuals must call 301-345-6700 or email reservatioins@hicollegepark.com to book reservations.
This extensive three day course focuses on non-clinical, early clinical, and phase 3 studies, issues in the design and analysis of trials, safety and ethical considerations and FDA's regulatory requirements related to the performance and evaluation of clinical studies. Attendees will have the unique opportunity of hearing directly from FDA’s nationally renowned experts on issues critical to successful clinical research. The course is designed for physicians, nurses, pharmacists and other health care professionals involved in clinical trials.
For more information on and to register for the course click here: http://continuingeducation.dcri.duke.edu/fda-clinical-investigators-training-course-registration
*You will need to create a profile prior to registering for this course. For instructions on how to set up a profile please see the instructions on the registration page.
The course fee is $400.00. Visa and Mastercard are accepted. CME credits are available.
Registration deadline has been extended to November 1, 2013.
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
